about to run, page-87

pity about the thread I must admit to being firmly in the FA camp with Dogbark on this one. The Peregrine crowd who created the issue and dump downtrend so fondly refered to by the against crowd are gone and the new management are in. Great board and chairman. 6 months to get the capital rasing settled in and the old Peregrine cronies out. QIC, BTC have come on board as well as other major shareholders. Beville family ($300m) behind it as well. Deals with Astra Z (news about to drop) and BioMira as well as other milestone deals with more than $20m in them. Arthron about to sign another licencing deal and haven't even sold the jewel out yet (the antibody). 60 minutes melanoma story last sunday night referred to a melanoma vaccine - PRR call it PVX-011 under their DCTag technology, ovarian cancer trial in Phase II at the moment with BioMira looking at an automatic exercise of their option and then it's free carried through to registration with double digit royalties. For the TA among us it has broken its downtrend - I wouldn't say it is in an uptrend although for the bulls out there you can see one very recently if you want to.

There is waay to much attention being paid to this stock (and I don't mean here on HC - that won't make a beesdick difference to whether or not it breaks up) and it seems some chunky buyers have been stepping up and they seems to have more capacity than the sellers more recently. Yesterday there was a 500k buyer but split the order - a little stock like this takes less than $500k to get it going if it is going to run. Whether its a new buyer or Bluscan or QIC deciding to add it won't take much.

I have said pretty consistently June/July although I acknowledged that there seems to be movement a little earlier than I had guessed.

Realistically it will probably calm down over the next few days - it is holding nicely the 10-12c range but is looking more like attacking the top side than the bottom.

SCE report says 33c is fair but they have an optimistic target of 88c - I disagreed with some of their assumptions and came up with the low 30's as well - since then there has been new patents which will assist PRR get a better deal with Astra (and all is going well on that front according to chatter) & new technology from the ARI plus progress on all other fronts. This is a second half of the year story and we are now 5 weeks away from the second half of the year.

If you are reading this thread and think this stock is a joke then please PM slayer at sharescence and I'll give you a copy of the SCE report and you can decide for yourself or just read through the posts since Feb over there and most of it is covered.

I know of doctors buying this stock and I have heard of BioMira staff buying. I know proffessional traders in Hong Kong buying it. We have seen QIC who have a dedicated biotech analyst buying a large stake at the same time they have been getting out of many biotechs. We have seen a proffessional biotech fund manager in BTC take thei MAXIMUM allowable allocation under their company rules - again PROFFESSIONAL biotech fund managers buying this stock.

I realise there are some hotcopper rampers on this thread and I truly wish they wouldn't operate that way but I do believe they are going to make lots of money out of this stock so good lck to them. Thre are also those expressing their opposing opinion - as with most who oppose a stock on HC their motivation usually comes from a previous altercation with a poster and they stalk them onto other threads or they are just sick of seeing the crappy ramper posts and end up engaging the rampers. To those who are stalking posters - it's just not worth it. To those sick of the ramper posts - I share your pain but engaging them just lets them fill HC with more posts on their stock which makes others look to see if there is something going on - and the ramp is successful. Hopefully they read a post like Dogbark's and actually understand the stock and do their own research.

If you don't like this stock be careful of your reasons why - if it is because of the ramping then leave yor comments to ramping - if its because of the sown trend then put it on you watch list because it has broken that down trend but is NOT yet in an uptrend (yes that is subject to your opinion) - if it is fundamentals of a biotech company you are going to pick on the know what you are on about because you will engage the likes of Dogbark or me and we have done a little too much reading on all that is PRR and have just kept buying and buying and buying.

Sometimes there are genuine stocks that are waay cheap - usually they are stock like PRR that have had crap management like the Peregrine crowd doing their funding run and dump cycles on them but all along the way this company has been using that funding and moving closer and closer to their goals and now it is time - usually just after all the faithful have been heavily diluted - just like in the case of PRR faithful - usually new management - just like PRR - usually new shareholders with PROFFESSIONAL expertise - like PRR in tha case of QIC & BTC and usually they have a slow turn out of a downtrend and then in a short space of time trade back to a 'fair' value before continuing on - again PRR looks like this.

8c or $1 or 30c today , tomorrow next week in 3 months in a year - come on punters - who cares if you are right or wrong - the only people who care are those who have invested - we stand to gain or lose based on our decisions - those who haven't - share you opinion and move on but don't waste you time on the rampers - you just fuel their cause - this is probably one of the most read threads in the last 24 hours all thanks to the rampers and the responders.

Something is up - they buying yesterday was a good pick up in vloume and seems well supported. There is talk in the wind of something happening and the chairman is in Melbourne for a week and there is no board meeting scheduled - maybe something to it but maybe not. Don't buy this stock for the chance of an announcement - convince yourself about the biotech sector being the next to run and that PRR is one of the best biotechs with multiple sciences at various stages with amazing agreements with big name pharma and has already done its funding for the next 2 years and it turning out of a downtreand and will only take a few hundred thousand dollars to be invested to break out and has professional fund managers buying and a greatly respected board (for example AML tried to get the most recent appointment but he chose Prima).

DYOR.

Pity about the tread but it has brought PRR into the light for HC's at just the right time. Do your research and decide for yourself but if you are reading this for the first time about PRR then you are lucky - I watched and waiting for this stock since it was 18-20c last year and closed out all my mining/energy trades in Feb/Mar this ear and have been buying biotechs over the same period with PRR my number one hold.

Did I mention DYOR?

Well this is worth looking into.